Log in to your Inderes Free account to see all free content on this page.
Genmab
1,729.50 DKK
-0.63 %
Less than 1K followers
GMAB
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Genmab
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (DKK) | 1,481.50 | 2,463.00 | 2,630.00 | 2,941.00 | 2,155.00 | 1,492.50 | 2,027.00 |
| Shares | 65.0 | 65.0 | 65.0 | 66.0 | 66.1 | 66.2 | 64.2 |
| Market cap | 96,248.6 | 160,013.7 | 170,863.2 | 193,993.0 | 142,390.6 | 98,784.4 | 130,211.3 |
| Enterprise value | 92,877.6 | 144,253.7 | 151,950.2 | 172,266.0 | 115,025.6 | 78,712.4 | - |
| EV/S | 17.3 | 14.3 | 17.9 | 11.8 | 7.0 | 3.7 | - |
| EV/EBITDA | 35.2 | 22.9 | 50.3 | 27.1 | 21.6 | 11.1 | - |
| EV/EBIT | 35.2 | 22.9 | 50.3 | 27.1 | 21.6 | 11.7 | - |
| P/E | 44.4 | 33.6 | 56.8 | 34.8 | 32.3 | 12.2 | 20.6 |
| P/B | 6.85 | 8.37 | 7.70 | 7.07 | 4.50 | 2.69 | 3.50 |
| P/S | 17.9 | 15.8 | 20.1 | 13.3 | 8.6 | 4.6 | 5.5 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 92.8 % | 90.4 % | 90.1 % | 90.6 % | 89.6 % | 80.1 % | 45.4 % |
| Gearing ratio | 1.3 % | 1.7 % | 1.9 % | 2.2 % | 2.4 % | 2.8 % | 92.8 % |
Login required
This content is only available for logged in users